This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Targovax Oy. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: Elina Haavisto: Innovator in Cancer Therapy
Introduction
Elina Haavisto is a prominent inventor based in Helsinki, Finland. She has made significant contributions to the field of cancer therapy through her innovative research and inventions. With a focus on combining adenovirus and checkpoint inhibitors, her work aims to enhance treatment options for cancer patients.
Latest Patents
Elina Haavisto holds 2 patents related to her groundbreaking work. Her latest patents include a combination therapy that utilizes an oncolytic adenovirus vector alongside checkpoint inhibitors. This invention specifically addresses the use of these components in cancer therapy, aiming to improve treatment efficacy and patient outcomes.
Career Highlights
Throughout her career, Elina has been associated with Targovax Oy, a company dedicated to developing innovative cancer therapies. Her role at Targovax has allowed her to focus on her research and contribute to advancements in the field of oncology.
Collaborations
Elina collaborates with talented individuals such as Tuuli Ranki and Sari Anneli Pesonen. These collaborations enhance her research efforts and contribute to the development of effective cancer treatments.
Conclusion
Elina Haavisto's work in combining adenovirus and checkpoint inhibitors represents a significant advancement in cancer therapy. Her innovative approach and dedication to research continue to pave the way for new treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile